Literature DB >> 12170436

Mohs micrographically controlled surgery and the treatment of malignant melanoma.

Constance Nagi1, Terence C O'Grady, Arash Izadpanah.   

Abstract

Mohs micrographic surgery is a technique that offers surgeons and pathologists a means to examine the entire surgical margins of excised cutaneous malignancies in a more complete manner than conventional methods. Initially developed to treat nonmelanoma skin cancers, its use has been expanded to include histologic margin evaluation for treatment of malignant melanoma. Clinical studies demonstrate equivalent or better 5-year survival rates with Mohs surgery compared to conventional wide local excision. For surgical treatment of melanoma, it offers unique advantages for lesions requiring tissue conservation and accurate margin determination, particularly in anatomic sites where cosmetic and functional concerns are of importance (head and neck, hands, and feet), and for large or ill-defined lesions such as lentigo maligna or lentigo maligna melanoma. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12170436     DOI: 10.1053/sonc.2002.34111

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  4 in total

1.  Management of cutaneous tumors with mohs micrographic surgery.

Authors:  Krisinda C Dim-Jamora; Jennifer B Perone
Journal:  Semin Plast Surg       Date:  2008-11       Impact factor: 2.314

2.  Detection limits of intraoperative near infrared imaging for tumor resection.

Authors:  Greg M Thurber; Jose-Luiz Figueiredo; Ralph Weissleder
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

Review 3.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20

4.  Combined Mohs Micrographic Surgery in a Collision Tumor.

Authors:  Rafael A Montealegre; Juan C Barrera
Journal:  Cureus       Date:  2022-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.